-+ 0.00%
-+ 0.00%
-+ 0.00%

Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.

Zhitongcaijing·11/16/2026 00:01:01
Listen to the news
Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.